{
    "Trade/Device Name(s)": [
        "Direct HDL Cholesterol for the ADVIA IMS",
        "ADVIA IMS Direct HDL Cholesterol"
    ],
    "Submitter Information": "Bayer HealthCare Diagnostics Division",
    "510(k) Number": "K050632",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBS"
    ],
    "Summary Letter Date": "May 26, 2005",
    "Summary Letter Received Date": "March 9, 2005",
    "Submission Date": "March 4, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "HDL Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA IMS systems"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Method"
    ],
    "Document Summary": "FDA 510(k) summary for Direct HDL Cholesterol quantitative method for ADVIA IMS systems measuring HDL Cholesterol in serum and plasma",
    "Indications for Use Summary": "For in vitro diagnostic use to measure HDL Cholesterol in human serum and plasma for cardiovascular disease risk assessment",
    "fda_folder": "Clinical Chemistry"
}